Plain English Summary
Background and study aims
Heart attacks are caused by a blood clot blocking the blood vessels of the heart, preventing blood getting to the heart muscle. Opening up the artery with a balloon (angioplasty) and a small mesh tube (stent) can cause this clot to break up and get washed downstream, which can make the heart attack worse. We have devices that can suck out the clot from the blood vessel (thrombectomy catheters). However, it is unclear whether patients benefit from this. We are interested in assessing blood flow and pressure in the blocked vessel to help guide the best use of these devices. We will assess the benefits of thrombectomy versus balloon angioplasty.
Who can participate?
Patients coming to the Cambridge Heart Attack Centre (Papworth Hospital) with a heart attack will be approached to participate in the study.
What does the study involve?
If you enrol in the study, there will be some additional stages to your angioplasty and stent procedure. The initial length of your hospital stay will not be altered by this study, but your procedure may take about 5-10 minutes longer. To assess the blood flow and pressure in your blocked artery causing your heart attack we will push a pressure/temperature wire past the blockage and take measurements using a drug called adenosine. These measurements will be performed three or four times (at each stage of your stenting procedure). We assess flow in the artery by injecting room temperature salt water into the artery, and measure temperature changes with a sensor on the wire tip. The pressure is also measured from tip of the wire. Adenosine will be given to you via a tube in your leg vein (inserted as part of your stenting procedure) each time we perform a pressure and flow assessment. Participants will be randomly allocated to receive treatment with either a clot suction device (thrombectomy microcatheter) and stents or will be managed with just balloon and stents alone (as is standard practice). After your stenting procedure we will take extra blood tests at 6, 12 and 24 hours. We will also perform a cardiac MRI the day after your stent procedure whilst you are still an inpatient. Another MRI scan of the heart will be performed as an outpatient 3 months after your stent procedure. Finally we will contact you by telephone at 6 months and 1 year to find out how you are doing.
What are the possible risks and benefits of participating?
There is no direct benefit from being in the study. However, adenosine has been shown to reduce the size of heart attacks and may be cardio-protective. This is not currently given as part of standard care. All patients will be treated according to standard practice guidance. Your doctor will have detailed images of the heart from cardiac MRI that may help with your ongoing management. We believe that the risk to you is small because we will take care to only recruit suitable patients. The adenosine infusion can cause flushing, wheeze, shivers and mild chest tightness, but this resolves very quickly. The body rapidly breaks down adenosine and any side effects quickly resolve when the infusion is stopped. Participation in this study requires that you have 3-4 adenosine infusions, so that we can measure the pressure and blood flow at each stage of your stenting procedure. Injections of saline (salt water) into the coronary artery are made throughout the procedure to prevent the blood clotting in our equipment. You will not feel this and it is safe. In half of the participants a suction microcatheter will be used to retrieve clot from the artery (thrombectomy) before the stenting procedure. This will require about 1 extra minute of X-ray screening corresponding to a dose equivalent to 6 months of background radiation with an additional risk of radiation-induced cancer of 1 in 24,000. However, the routine angioplasty and stent procedure has a radiation dose of about 17 times this amount and the radiation exposure for the procedure is highly variable from individual to individual. There is no radiation involved in the cardiac MRI scans.
Where is the study run from?
Papworth Hospital NHS Foundation Trust (UK).
When is the study starting and how long is it expected to run for?
The study started in April 2012 and will run for 4 years.
Who is funding the study?
Biomedical Research Council (UK).
Who is the main contact?
Dr Stephen Hoole
Tel: +44 (0) 1480364119
Stephen.hoole@papworth.nhs.uk
Trial website
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
Version 2.0
Study information
Scientific title
Serial assessment of the index of microcirculatory resistance during primary percutaneous coronary intervention comparing manual aspiration catheter thrombectomy with balloon angioplasty (IMPACT study): a randomized controlled pilot study
Acronym
IMPACT
Study hypothesis
Manual thrombectomy is superior to balloon angioplasty to maintain the microcirculation during primary percutaneous coronary intervention (PCI) treatment.
Ethics approval
Cambridgeshire 3 REC, 01/04/2012, ref: 08/H0306/49
Study design
Single-blind randomized controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Acute myocardial infarction
Intervention
Participants will be randomised to receive one of the following two treatments:
1. Manual thrombectomy with a thrombus aspiration microcatheter (suction before stenting)
2. Balloon angioplasty with a balloon (stretch before stenting)
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measures
Index of Microcirculatory Resistance (IMR) at the end of the PPCI procedure
Secondary outcome measures
1. Troponin at 12 and 24 hours
2. Cardiac MRI determined infarct size at day 1 and month 3
Overall trial start date
01/06/2010
Overall trial end date
01/06/2014
Reason abandoned
Eligibility
Participant inclusion criteria
1. Patients with ST segment elevation myocardial infarction (STEMI) or new left bundle branch block (LBBB), <12 hours since symptom onset and with partial restoration of coronary artery flow after passage of a guide wire
2. Age 18-100 years
3. Male or female
Participant type
Patient
Age group
Other
Gender
Both
Target number of participants
40
Participant exclusion criteria
1. Patient unable to consent
2. Cardiogenic shock
3. Unfavourable coronary anatomy
4. Surgical disease
5. Baseline Thrombolysis In Myocardial Infarction (TIMI) flow score = 0
6. Contra-indication to adenosine
7. Heart block
8. Severe airways disease
Recruitment start date
01/06/2010
Recruitment end date
01/06/2014
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Papworth Hospital
Cambridge
CB23 3RE
United Kingdom
Sponsor information
Organisation
Papworth Hospital NHS Foundation Trust (UK)
Sponsor details
Papworth Everard
Cambridge
CB23 3RE
United Kingdom
Sponsor type
Hospital/treatment centre
Website
Funders
Funder type
Research council
Funder name
Biomedical Research Council (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
2015 results in https://www.ncbi.nlm.nih.gov/pubmed/26019882